Data on new Alzheimer’s drug and Black patients is sparse
1 min read
Data on how the drugs work in Black patients is sparse — despite the fact that they develop Alzheimer’s at twice the rate of White people. That has some experts worrying that the drug won’t work as well for African Americans and may expose them to extra safety risks.
Laurie McGinley, McKenzie Beard
2024-01-29 07:57:30
All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator
Read more from original source here…
